NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 181 filers reported holding NOVAVAX INC in Q1 2016. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2018 | $9,000 | -18.2% | 4,900 | -16.9% | 0.00% | – |
| Q3 2018 | $11,000 | +22.2% | 5,900 | -10.4% | 0.00% | – |
| Q2 2018 | $9,000 | +50.0% | 6,585 | +46.8% | 0.00% | – |
| Q1 2018 | $6,000 | 0.0% | 4,485 | 0.0% | 0.00% | – |
| Q4 2017 | $6,000 | -64.7% | 4,485 | -70.0% | 0.00% | -100.0% |
| Q3 2017 | $17,000 | 0.0% | 14,960 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $17,000 | -63.0% | 14,960 | -57.9% | 0.00% | -50.0% |
| Q1 2017 | $46,000 | 0.0% | 35,550 | -3.7% | 0.00% | 0.0% |
| Q4 2016 | $46,000 | -45.9% | 36,900 | -9.9% | 0.00% | -50.0% |
| Q3 2016 | $85,000 | -65.2% | 40,950 | +22.2% | 0.00% | -71.4% |
| Q2 2016 | $244,000 | +4.7% | 33,500 | +20.4% | 0.01% | -12.5% |
| Q4 2015 | $233,000 | – | 27,816 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alden Global Capital LLC | 600,000 | $4,362,000 | 3.76% |
| DAFNA Capital Management LLC | 550,000 | $3,999,000 | 3.17% |
| BB BIOTECH AG | 8,330,000 | $60,559,000 | 2.39% |
| HARVEY CAPITAL MANAGEMENT INC | 602,750 | $4,381,000 | 2.20% |
| NORTHPOINTE CAPITAL LLC | 2,124,035 | $15,442,000 | 1.82% |
| Cormorant Asset Management, LP | 1,619,608 | $11,775,000 | 1.67% |
| WILLIAM HARRIS INVESTORS INC | 667,922 | $4,856,000 | 1.22% |
| Eventide Asset Management | 2,179,700 | $15,846,000 | 0.97% |
| SECTORAL ASSET MANAGEMENT INC | 912,305 | $6,632,000 | 0.68% |
| Rock Springs Capital Management LP | 852,500 | $6,198,000 | 0.46% |